• Amicus Therapeutics Announces New Drug Application

    Amicus Therapeutics has received outstanding news from the U.S. Food and Drug Administration (FDA) that its application for a new drug to treat Fabry disease may go forward. Amicus Therapeutics is expected to submit a new drug application for migalastat sometime during the last quarter of this year. The...